Compare Heron Therapeutics Inc (HRTX) vs YieldMax Magnificent 7 Fund of Option Income ETFs (YMAG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs YieldMax Magnificent 7 Fund of Option Income ETFs — how do they compare? Heron Therapeutics Inc trades at $0.46 (market cap $91.46M), while YieldMax Magnificent 7 Fund of Option Income ETFs trades at $11.67. Which is the better fit depends on your goals.
| HRTX | YMAG | |
|---|---|---|
Market Cap | $91.46M | — |
Sector | Health | Income / Options Overlay |
52-Week High | $1.96 | $15.98 |
52-Week Low | $0.39 | $11.00 |
Enterprise Value | $189.36M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About YieldMax Magnificent 7 Fund of Option Income ETFs
YMAG is an actively managed 'fund of funds' that provides equal-weighted exposure to the seven YieldMax ETFs tracking the 'Magnificent 7' tech giants (Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta, and Tesla). It seeks to generate high current income by harvesting option premiums across these leaders, offering a streamlined way to access concentrated tech volatility in an income-producing format.
Read more on YMAG →
